Thromboreductin

Recall | Medicines | 26/02/2015

The distribution company has informed its supplied customers in a letter dated 25.02.2015 that in the instructions for use of this batch the wrong daily maximum dose of ten capsules is indicated. This medicinal product is placed on the market in Austria within the scope of a transfer notification pursuant to the Austrian Medicinal Products Import Act 2010.

Name of the medicinal product Thromboreductin 1,0 mg Kapseln
Marketing authorisation number(s) Nicht bekannt, im Ausland zugelassene Arzneispezialität
Marketing authorisation holder AOP Orphan Pharmaceuticals AG
Batch number(s) Z875A
Classification of the recall2
BASG reference number INS - 640.001 - 1348
Email

Further inquiry note